Capital expenditure · 2011–2025
Emergent Biosolutions capital expenditure
$13.8M−39.7% · FY2025
Emergent Biosolutions (EBS) reported $13.8M in capital expenditure for fiscal 2025, −39.7% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $13.8M | −39.7% | Open → |
| FY20242024-12-31 | $22.9M | −55.6% | Open → |
| FY20232023-12-31 | $51.6M | −55.4% | Open → |
| FY20222022-12-31 | $116M | −48.3% | Open → |
| FY20212021-12-31 | $224M | +57.9% | Open → |
| FY20202020-12-31 | $142M | +63.3% | Open → |
| FY20192019-12-31 | $86.9M | +20.5% | Open → |
| FY20182018-12-31 | $72.1M | +31.6% | Open → |
| FY20172017-12-31 | $54.8M | −28.1% | Open → |
| FY20162016-12-31 | $76.2M | +70.0% | Open → |
| FY20152015-12-31 | $44.8M | +46.1% | Open → |
| FY20142014-12-31 | $30.7M | −27.0% | Open → |
| FY20132013-12-31 | $42.0M | −22.0% | Open → |
| FY20122012-12-31 | $53.8M | −0.3% | Open → |
| FY20112011-12-31 | $54.0M | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth −9.3%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Emergent Biosolutions capital expenditure |url=https://companiesranked.com/en/company/emergent-biosolutions/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Emergent Biosolutions capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/emergent-biosolutions/capital-expenditureBibTeX
@misc{companiesranked-en-company-emergent-biosolutions-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Emergent Biosolutions capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/emergent-biosolutions/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001367644-26-000015 · February 27, 2026
{{cite web |title=Emergent Biosolutions capital expenditure — 10-K (0001367644-26-000015) |url=https://www.sec.gov/Archives/edgar/data/1367644/000136764426000015/ebs-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.